PROJECT

Projects

Summary of Investment Information

Project Number

32926

Company Name

HELIX LABORATORY SERVICE

Date SPI Disclosed

Nov 25, 2013

Country

Russian Federation

Region

Europe

Projected Board Date

Dec 26, 2013

Environmental Category

B - Limited

Status

Completed

Last Updated Date

Jun 12, 2021

Department

Regional Industry MAS LAC & EUR

Industry

Health, Education and Life Sciences

Previous Events

Approved : Feb 10, 2014
Signed : Mar 4, 2014
Invested : May 5, 2014

Sector

Medical Laboratories

Project Description

IFC proposes to support the expansion of NPF Helix, a privately held independent chain of in-vitro diagnostic (IVD) medical laboratories. The Company offers a wide variety of tests including clinical, chemistry, coagulation, immuno-chemistry, microbiology and molecular diagnostic. Helix has a strong emphasis on quality, including certification and audit by outside parties. In addition to Russian quality certifications for diagnostic laboratories, the company has ISO 9001:2008 certification. The project entails expansion of the existing laboratories in St. Petersburg and Yekaterinburg, establishment of a new laboratory in Moscow and widening the Company network of diagnostic centers and sample collection points (the “Project”).

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation